These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 1332066)

  • 1. Allelic deletions in the long arm of chromosome 12 identify sites of candidate tumor suppressor genes in male germ cell tumors.
    Murty VV; Houldsworth J; Baldwin S; Reuter V; Hunziker W; Besmer P; Bosl G; Chaganti RS
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):11006-10. PubMed ID: 1332066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetic changes in human male germ cell tumors.
    Lothe RA; Peltomäki P; Tommerup N; Fosså SD; Stenwig AE; Børresen AL; Nesland JM
    Lab Invest; 1995 Nov; 73(5):606-14. PubMed ID: 7474934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic and molecular analysis of human male germ cell tumors: chromosome 12 abnormalities and gene amplification.
    Samaniego F; Rodriguez E; Houldsworth J; Murty VV; Ladanyi M; Lele KP; Chen QG; Dmitrovsky E; Geller NL; Reuter V
    Genes Chromosomes Cancer; 1990 Mar; 1(4):289-300. PubMed ID: 2177638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis.
    Houldsworth J; Reuter V; Bosl GJ; Chaganti RS
    Cell Growth Differ; 1997 Mar; 8(3):293-9. PubMed ID: 9056671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytogenetic aspects of pediatric germ cell tumors].
    Stock C; Ambros IM; Strehl S; Zoubek A; Fink FM; Gadner H; Ambros PF
    Klin Padiatr; 1995; 207(4):235-41. PubMed ID: 7564160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isochromosome 12p in non-seminoma cell lines: karyologic amplification of c-ki-ras2 without point-mutational activation.
    Dmitrovsky E; Murty VV; Moy D; Miller WH; Nanus D; Albino AP; Samaniego F; Bosl G; Chaganti RS
    Oncogene; 1990 Apr; 5(4):543-8. PubMed ID: 2183156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 12q heterozygosity is retained in i(12p)-positive testicular germ cell tumor cells.
    Geurts van Kessel A; van Drunen E; de Jong B; Oosterhuis JW; Langeveld A; Mulder MP
    Cancer Genet Cytogenet; 1989 Jul; 40(1):129-34. PubMed ID: 2569358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity of tumor suppressor genes in testis cancer.
    Peng HQ; Bailey D; Bronson D; Goss PE; Hogg D
    Cancer Res; 1995 Jul; 55(13):2871-5. PubMed ID: 7796415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity on chromosome arms 5q, 11p, 11q, 13q, and 16p in human testicular germ cell tumors.
    al-Jehani RM; Povey S; Delhanty JD; Parrington JM
    Genes Chromosomes Cancer; 1995 Aug; 13(4):249-56. PubMed ID: 7547632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of the i(12p) marker chromosome in germ cell tumors.
    Bosl GJ; Ilson DH; Rodriguez E; Motzer RJ; Reuter VE; Chaganti RS
    J Natl Cancer Inst; 1994 Mar; 86(5):349-55. PubMed ID: 8308927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas.
    Ransom DT; Ritland SR; Moertel CA; Dahl RJ; O'Fallon JR; Scheithauer BW; Kimmel DW; Kelly PJ; Olopade OI; Diaz MO
    Genes Chromosomes Cancer; 1992 Nov; 5(4):357-74. PubMed ID: 1283325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives on testicular germ cell neoplasms.
    Cheng L; Lyu B; Roth LM
    Hum Pathol; 2017 Jan; 59():10-25. PubMed ID: 27569298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. i(12p)-negative testicular germ cell tumors. A different group?
    Castedo SM; de Jong B; Oosterhuis JW; Seruca R; Idenburg VJ; Buist J; Sleijfer DT
    Cancer Genet Cytogenet; 1988 Oct; 35(2):171-8. PubMed ID: 2846146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of loss of heterozygosity with cytogenetic analysis using G-banding and fluorescence in situ hybridization in aneuploid cultures from two human testicular germ-cell tumors.
    al-Jehani RM; Wells D; Fox M; Parrington JM
    Cancer Genet Cytogenet; 1995 Nov; 85(1):26-36. PubMed ID: 8536234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonrandom chromosome abnormalities in testicular and ovarian germ cell tumor cell lines.
    Murty VV; Dmitrovsky E; Bosl GJ; Chaganti RS
    Cancer Genet Cytogenet; 1990 Nov; 50(1):67-73. PubMed ID: 2253191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetic perspective of male germ cell tumors.
    Murty VV; Chaganti RS
    Semin Oncol; 1998 Apr; 25(2):133-44. PubMed ID: 9562446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reviews of chromosome studies in urological tumors. III. Cytogenetics and genes in testicular tumors.
    Sandberg AA; Meloni AM; Suijkerbuijk RF
    J Urol; 1996 May; 155(5):1531-56. PubMed ID: 8627820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verification of isochromosome 12p and identification of other chromosome 12 aberrations in gonadal and extragonadal human germ cell tumors by bicolor double fluorescence in situ hybridization.
    Suijkerbuijk RF; Looijenga L; de Jong B; Oosterhuis JW; Cassiman JJ; Geurts van Kessel A
    Cancer Genet Cytogenet; 1992 Oct; 63(1):8-16. PubMed ID: 1330288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors.
    Mathew S; Murty VV; Bosl GJ; Chaganti RS
    Cancer Res; 1994 Dec; 54(23):6265-9. PubMed ID: 7954476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human testicular cancer. Changes in autosomal dosage.
    Peltomäki P; Halme A; de la Chapelle A
    Cancer Genet Cytogenet; 1990 Aug; 48(1):1-12. PubMed ID: 1973631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.